-

Akanda to Participate in Benzinga Cannabis Capital Conference International Panel on September 13, 2022

CEO Tej Virk to Speak on International Panel at Upcoming Conference

LONDON--(BUSINESS WIRE)--International medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced that Chief Executive Officer Tej Virk will attend the Benzinga Cannabis Capital Conference in Chicago on September 13 and 14. Virk will speak on an expert panel with executives from other international cannabis companies and be available for 1x1 meetings with investors and media throughout the event.

The panel, “M&A Fever: Consolidation Heating Up in Canada & Europe,” is scheduled for 2:30 p.m. CT (3:30 p.m ET) on September 13, and will be streamed live on Benzinga’s YouTube channel here. It will be moderated by Michelle Donovan, Senior Counsel at Clark Hill, and include executives from Flora Growth, Lyphe Group and Sundial.

To schedule a meeting at the conference, please reach out to ir@akandacorp.com.

About Akanda Corp.

Akanda is an international medical cannabis and wellness platform company seeking to help people lead better lives through improved access to high quality and affordable products. Akanda’s portfolio includes Bophelo Bioscience & Wellness, a GACP qualified cultivation campus in the Kingdom of Lesotho in Southern Africa; Holigen, a Portugal-based cultivator, manufacturer and distributor with a prized EU GMP certified indoor grow facility; and CanMart, a UK-based fully licensed pharmaceutical importer and distributor which supplies pharmacies and clinics within the UK. The Company’s seed-to-patient supply chain also includes partnerships with Cellen Life Sciences’ Leva Clinic, one of the first fully digital pain clinics in the UK, and other leading distributors of medical cannabis in Germany.

Connect with Akanda: Website | LinkedIn | Twitter | Instagram

Contacts

Investors
Matt Chesler, CFA
FNK IR
ir@akandacorp.com

Media
Imogen Saunders
Irvine Partners
imogen@irvinepartners.co.uk

Industry:

Akanda Corp.

NASDAQ:AKAN
Details
Headquarters: Toronto, Ontario, Canada
CEO: Tej Virk
Employees: 45
Organization: PUB
Release Versions
English

Contacts

Investors
Matt Chesler, CFA
FNK IR
ir@akandacorp.com

Media
Imogen Saunders
Irvine Partners
imogen@irvinepartners.co.uk

Social Media Profiles
Akanda on Facebook
Akanda on Instagram
Akanda on LinkedIn
Akanda on Twitter
More News From Akanda Corp.

Akanda Corp. Announces Signing of Option to Develop Canadian THC and CBD Farming Facility

FRANKFURT, Germany & LONDON--(BUSINESS WIRE)--International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that Akanda (the “Optionee” the “Company”) and 1107385 B.C. LTD (the “Owner”) have agreed upon terms to purchase farming land and related operations and licenses. The key deal terms are as follows: Akanda will issue a non-refundable payment equal to One Million Eight Hundred Thousand United States Dollars (USD1,800,000) and if paid i...

Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

LONDON--(BUSINESS WIRE)--International medical cannabis platform company Akanda Corp. ("Akanda" or the “Company”) (NASDAQ: AKAN) today announced that the Company has received a written notification (the “Notification Letter”) on July 3, 2023 from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that it is not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2). It resulted from the fact that th...

Akanda Corp. Announces Termination of Loan Agreement

FRANKFURT, Germany & LONDON--(BUSINESS WIRE)--International Medical Cannabis Company, Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83) announces that Akanda and Veridia Canada Ltd. (the “Lender”) have mutually agreed to terminate the loan agreement between the parties previously announced on April 18, 2023 (the “Loan Agreement”). Akanda has returned all funds provided under the terms of the Loan Agreement and has no further obligations owing to the Lender pursuant to the Loa...
Back to Newsroom